8-K
filed August 8, 2023, 7:59 PM ET
ticker AZTA
CIK 0000933974
earnings
confidence high
sentiment positive
materiality 0.75
Azenta Q3 revenue up 25% YoY to $166M; guides Q4 $155-173M
Azenta, Inc.
2023-Q3 EPS reported
-$0.26
revenue$492,715,000
- Revenue $166M, up 25% YoY; organic growth 2%; Life Sciences Products +57%, Services +7%.
- GAAP diluted EPS from cont ops ($0.04); non-GAAP diluted EPS $0.13, up from $0.12 YoY.
- Adjusted EBITDA $13M (7.8% margin); free cash flow $9M in quarter.
- Q4 FY2023 guidance: total revenue $155-173M, non-GAAP EPS ($0.02)-$0.06.
- FYTD repurchased 16M shares for $764M; on track for $1B buyback by end of CY2023.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Azenta, Inc. reported fourth quarter of fiscal 2023 results: revenue $155 to $173 million, EPS ($0.02) to $0.06. Guidance initiated.
- Period
- fourth quarter of fiscal 2023
- Revenue
- $155 to $173 million
- EPS
- ($0.02) to $0.06
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Total revenue is expected to be in the range of $155 to $173 million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Azenta, Inc. reported third quarter ended June 30, 2023 results: revenue $166 million, EPS ($0.04).
- Period
- third quarter ended June 30, 2023
- Revenue
- $166 million
- EPS
- ($0.04)
- Result
- reported results
Exact text from the filing
confident in the unique value we bring to our customer partnerships across pharmaceutical, biotech, and academic institutions.” Third Quarter Fiscal 2023 Results ● Revenue was $166 million, up 25% year over year and 12% sequentially. Organic revenue increased 2% year over year, which excludes the impacts from foreign exchange headwinds of less than 1 percent and
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.